Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
Endocrine
|
October 29, 2014
Use of GLP-1 mimetic in type 2 diabetes mellitus: is it the end of fragility fractures?
Guillaume Mabilleau
Current Opinion in Pharmacology
|
April 29, 2015
Incretins and bone: friend or foe?
Guillaume Mabilleau
Expert Review of Endocrinology & Metabolism
|
October 16, 2020
Update on: effects of anti-diabetic drugs on bone metabolism
Guillaume Mabilleau, Béatrice Bouvard
Nature Reviews. Endocrinology
|
June 10, 2024
Gut hormones and bone homeostasis: potential therapeutic implications
Béatrice Bouvard, Guillaume Mabilleau
Calcified Tissue International
|
June 6, 2023
Validation of Fourier Transform Infrared Microspectroscopy for the Evaluation of Enzymatic Cross-Linking of Bone Collagen
Aleksandra Mieczkowska, Guillaume Mabilleau
Peptides
|
April 24, 2024
Gut hormone analogues and skeletal health in diabetes and obesity: Evidence from preclinical models
Guillaume Mabilleau, Béatrice Bouvard
Plos One
|
January 13, 2009
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
Guillaume Mabilleau, Afsie Sabokbar
Trends in Endocrinology and Metabolism: TEM
|
April 25, 2021
Osteomorphs as a tool for personalized medicine
Guillaume Mabilleau, Hélène Libouban, Valérie Geoffroy
The Journal of Biological Chemistry
|
December 4, 2010
Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis
Guillaume Mabilleau, Daniel Chappard, Afsie Sabokbar
Trends in Molecular Medicine
|
April 3, 2021
Predicting Bone Regeneration with a Simple Blood Test
Guillaume Mabilleau, Yves Delneste, Nicolas Papon
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
Endocrine
|
October 29, 2014
Use of GLP-1 mimetic in type 2 diabetes mellitus: is it the end of fragility fractures?
Guillaume Mabilleau
Current Opinion in Pharmacology
|
April 29, 2015
Incretins and bone: friend or foe?
Guillaume Mabilleau
Expert Review of Endocrinology & Metabolism
|
October 16, 2020
Update on: effects of anti-diabetic drugs on bone metabolism
Guillaume Mabilleau, Béatrice Bouvard
Nature Reviews. Endocrinology
|
June 10, 2024
Gut hormones and bone homeostasis: potential therapeutic implications
Béatrice Bouvard, Guillaume Mabilleau
Calcified Tissue International
|
June 6, 2023
Validation of Fourier Transform Infrared Microspectroscopy for the Evaluation of Enzymatic Cross-Linking of Bone Collagen
Aleksandra Mieczkowska, Guillaume Mabilleau
Peptides
|
April 24, 2024
Gut hormone analogues and skeletal health in diabetes and obesity: Evidence from preclinical models
Guillaume Mabilleau, Béatrice Bouvard
Plos One
|
January 13, 2009
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
Guillaume Mabilleau, Afsie Sabokbar
Trends in Endocrinology and Metabolism: TEM
|
April 25, 2021
Osteomorphs as a tool for personalized medicine
Guillaume Mabilleau, Hélène Libouban, Valérie Geoffroy
The Journal of Biological Chemistry
|
December 4, 2010
Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis
Guillaume Mabilleau, Daniel Chappard, Afsie Sabokbar
Trends in Molecular Medicine
|
April 3, 2021
Predicting Bone Regeneration with a Simple Blood Test
Guillaume Mabilleau, Yves Delneste, Nicolas Papon
Page
of 8